Squarepoint’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$585K Sell
156,126
-17,741
-10% -$69.9K ﹤0.01% 3207
2025
Q4
$614K Sell
173,867
-1,076
-0.6% -$4.37K ﹤0.01% 3046
2025
Q3
$700K Buy
174,943
+148,060
+551% +$467K ﹤0.01% 2951
2025
Q2
$72K Sell
26,883
-64,990
-71% -$137K ﹤0.01% 4249
2025
Q1
$130K Sell
91,873
-15,358
-14% -$26.1K ﹤0.01% 4146
2024
Q4
$213K Buy
107,231
+31,839
+42% +$83.3K ﹤0.01% 4422
2024
Q3
$237K Buy
+75,392
New +$238K ﹤0.01% 3594
2023
Q3
Sell
-44,641
Closed -$96K 3729
2023
Q2
$96K Sell
44,641
-59,906
-57% -$135K ﹤0.01% 3370
2023
Q1
$204K Buy
+104,547
New +$386K ﹤0.01% 2796
2022
Q3
Sell
-11,014
Closed -$88K 2937
2022
Q2
$88K Buy
+11,014
New +$104K ﹤0.01% 2638

Other funds holding ADCT